aTyr Pharma, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
22.00
|
|
Average Rating
|
4.43
|
|
# Strong Buys
|
3
|
|
# Buys
|
4
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2024-09-30
|
-0.22
|
-0.23
|
-0.01
|
-3.50%
|
|
2024-06-30
|
-0.24
|
-0.23
|
0.01
|
6.00%
|
|
2024-03-31
|
-0.24
|
-0.23
|
0.01
|
4.17%
|
|
2023-12-31
|
-0.24
|
-0.25
|
-0.01
|
-4.17%
|
|
2023-09-30
|
-0.23
|
-0.20
|
0.03
|
13.04%
|
|
2023-06-30
|
0.00
|
-0.22
|
0.00
|
0.00%
|
|
2023-03-31
|
0.00
|
-0.29
|
0.00
|
0.00%
|
|
2022-12-31
|
0.00
|
-0.26
|
0.00
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2024-09-30
|
-0.68
|
|
2023-12-31
|
-0.96
|
|
2022-12-31
|
-1.60
|
|
2021-12-31
|
-1.88
|
|
2020-12-31
|
-1.58
|
|
2019-12-31
|
-30.77
|
|
2018-12-31
|
-16.15
|
|
2017-12-31
|
-26.51
|
|
2016-12-31
|
-56.80
|